161 related articles for article (PubMed ID: 34549902)
1. Polymorphisms in NQO1 and MPO genes and risk for bladder cancer in Tunisian population.
Hemissi I; Ayed H; Naimi Z; Meddeb K; Ayadi M; Zouari S; Zaghbib S; Talbi E; Chebil M; Ouerhani S
Mol Genet Genomic Med; 2021 Nov; 9(11):e1819. PubMed ID: 34549902
[TBL] [Abstract][Full Text] [Related]
2. Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.
Zhang H; Wen X; Lu X; Zhang H
Tumour Biol; 2013 Dec; 34(6):3377-81. PubMed ID: 23873104
[TBL] [Abstract][Full Text] [Related]
3. [Genetic polymorphisms of MPO, NQO1, GSTP1, UGT1A6 associated with susceptibility of chronic benzene poisoning].
Sun P; Zhang Z; Wan J; Shao M
Wei Sheng Yan Jiu; 2007 Jan; 36(1):11-5. PubMed ID: 17424838
[TBL] [Abstract][Full Text] [Related]
4. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis.
Gong M; Yi Q; Wang W
Tumour Biol; 2013 Oct; 34(5):2551-6. PubMed ID: 23749485
[TBL] [Abstract][Full Text] [Related]
5. CYP2E1 and NQO1 genotypes, smoking and bladder cancer.
Choi JY; Lee KM; Cho SH; Kim SW; Choi HY; Lee SY; Im HJ; Yoon KJ; Choi H; Choi I; Hirvonen A; Hayes RB; Kang D
Pharmacogenetics; 2003 Jun; 13(6):349-55. PubMed ID: 12777965
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of NQO1 Pro187Ser or SULT1A1 Arg213His polymorphism and smoking on bladder cancer risk: Two meta-analyses.
Wang XC; Wang J; Tao HH; Zhang C; Xu LF
Int J Occup Med Environ Health; 2017 Jul; 30(5):791-802. PubMed ID: 28589969
[TBL] [Abstract][Full Text] [Related]
7. Human NAD(P)H:quinone oxidoreductase 1 (NQO1) and sulfotransferase 1A1 (SULT1A1) polymorphisms and urothelial cancer risk in Taiwan.
Wang YH; Lee YH; Tseng PT; Shen CH; Chiou HY
J Cancer Res Clin Oncol; 2008 Feb; 134(2):203-9. PubMed ID: 17619904
[TBL] [Abstract][Full Text] [Related]
8. [Genetic polymorphisms of NQO1, GSTT1, GSTM1 and susceptibility to chronic benzene poisoning].
Chen Y; Li GL; Ji ZY; Xu JN; Wu CL
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Feb; 23(1):1-5. PubMed ID: 15748501
[TBL] [Abstract][Full Text] [Related]
9. Association of bladder cancer risk with an NAD(P)H:quinone oxidoreductase polymorphism in an ethnic Kashmiri population.
Pandith AA; Khan NP; Shah ZA; Shah AM; Wani SM; Siddiqi MA
Biochem Genet; 2011 Aug; 49(7-8):417-26. PubMed ID: 21253823
[TBL] [Abstract][Full Text] [Related]
10. Association of polymorphisms in iNOS and NQO1 with bladder cancer risk in cigarette smokers.
Huang ZM; Chen HA; Chiang YT; Shen CH; Tung MC; Juang GD
J Chin Med Assoc; 2014 Feb; 77(2):83-8. PubMed ID: 24315573
[TBL] [Abstract][Full Text] [Related]
11. Genetic polymorphisms in NQO1 and SOD2: interactions with smoking, schistosoma infection, and bladder cancer risk in Egypt.
Goerlitz D; Amr S; Dash C; Saleh DA; El Daly M; Abdel-Hamid M; El Kafrawy S; Hifnawy T; Ezzat S; Abdel-Aziz MA; Khaled H; Zheng YL; Mikhail N; Loffredo CA
Urol Oncol; 2014 Jan; 32(1):47.e15-20. PubMed ID: 24035474
[TBL] [Abstract][Full Text] [Related]
12. Association of genetic polymorphisms in CYP2E1, MPO, NQO1, GSTM1, and GSTT1 genes with benzene poisoning.
Wan J; Shi J; Hui L; Wu D; Jin X; Zhao N; Huang W; Xia Z; Hu G
Environ Health Perspect; 2002 Dec; 110(12):1213-8. PubMed ID: 12460800
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk.
Hung RJ; Boffetta P; Brennan P; Malaveille C; Gelatti U; Placidi D; Carta A; Hautefeuille A; Porru S
Carcinogenesis; 2004 Jun; 25(6):973-8. PubMed ID: 14729580
[TBL] [Abstract][Full Text] [Related]
14. The NQO1 rs1800566 polymorphism and risk of bladder cancer: evidence from 6,169 subjects.
Guo ZJ; Feng CL
Asian Pac J Cancer Prev; 2012; 13(12):6343-8. PubMed ID: 23464456
[TBL] [Abstract][Full Text] [Related]
15. Genetic variants of NQO1 gene increase bladder cancer risk in Indian population and meta-analysis.
Mandal RK; Dubey S; Panda AK; Mittal RD
Tumour Biol; 2014 Jul; 35(7):6415-23. PubMed ID: 24676794
[TBL] [Abstract][Full Text] [Related]
16. [Relationship of MPO and NQO1 gene polymorphisms with susceptibility to acute leukemia].
Jia MF; Xi YM; Shi XE; Zhang H; Deng W; Li M; Li P; Xu JW; Ma HZ; Yao XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1336-40. PubMed ID: 23257428
[TBL] [Abstract][Full Text] [Related]
17. An association between NQO1 genetic polymorphism and risk of bladder cancer.
Park SJ; Zhao H; Spitz MR; Grossman HB; Wu X
Mutat Res; 2003 Apr; 536(1-2):131-7. PubMed ID: 12694753
[TBL] [Abstract][Full Text] [Related]
18. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
19. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis.
Chao C; Zhang ZF; Berthiller J; Boffetta P; Hashibe M
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):979-87. PubMed ID: 16702380
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H:Quinone oxidoreductase-1 C609T polymorphism analysis in human superficial bladder cancers: relationship of genotype status to NQO1 phenotype and clinical response to Mitomycin C.
Basu S; Brown JE; Flannigan GM; Gill JH; Loadman PM; Martin SW; Naylor B; Puri R; Scally AJ; Seargent JM; Shah T; Phillips RM
Int J Oncol; 2004 Oct; 25(4):921-7. PubMed ID: 15375541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
